PTEN and cancer: In particular, alterations in or deregulation of multiple pathways in cancer cells, including the MAPK/PTEN/PI3K, WNT/β-catenin, JAK/STAT, interferon-γ, and antigen processing/presentation pathways, have been shown to be associated with resistance to ICB2,3,5.